INTRODUCTION
Glycosyltransferases (GTs, EC 2.4.x.y) are enzymes that catalyze the transfer of a sugar moiety from an activated sugar donor onto a sugar acceptor or an aglycone, resulting in sugar-containing products. GTs are widely distributed in nature, and play a central role in the structural and physiological aspects of living organisms; they are involved in the synthesis of oligosaccharides, polysaccharides, glycoproteins, glycolipids, glycosylated natural products, and many others (Breton et al., 2006; Elshahawi et al., 2015; Wagner and Pesnot, 2010) . Consequently, there are currently more than 150,000 genes believed to encode members of the >90 families of GTs listed in the databases (NCBI, CAZy; http://www.cazy.org), and this number is growing rapidly (Hansen et al., 2010) .
Despite the large number of families of GTs with diverse primary sequences and functions, to date only two distinct structural folds are known for most nucleotide sugar-dependent GTs: GT-A and GT-B folds. The GT-A fold is characterized by a single domain fold, made up of an a/b/a sandwich (a seven-stranded b-sheet core flanked by a helices) that resembles a Rossmann fold (Breton et al., 2006) . The central b sheet is flanked by a small antiparallel b sheet connected by a metal-coordinating DXD motif-containing loop, and together they form the active site . On the other hand, the crystal structures of GT-B GTs revealed that they consist of two distinct b/a/b Rossmann-like domains in non-abutting opposing orientation, with a catalytic site located between the domains. The N-terminal domain is responsible for the acceptor binding, whereas the C-terminal domain is responsible for nucleotide donor binding Vrielink et al., 1994) .
Recently, we discovered a number of putative GTs that can catalyze non-glycosidic C-N couplings in the biosynthesis of pseudosugar-containing natural products, such as the a-glucosidase inhibitors acarbose and amylostatins, the antibiotic pyralomicin 1a, and the antifungal agent validamycin A (Figure 1 ) (Asamizu et al., 2013 (Asamizu et al., , 2011 Flatt et al., 2013) . The term ''pseudosugars'' refers to analogs of monosaccharides in which the ring oxygen has been replaced by a methylene group (Barbaud et al., 1995; Barton et al., 1988; Brunkhorst et al., 1999; Callam and Lowary, 2000; Suami and Ogawa, 1990; Yoshikawa et al., 1994) . The enzymes that catalyze the transfer of pseudosugars, or pseudoglycosyltransferases (PsGTs), are believed to have evolved from ancestral GTs. Our recent studies on VldE, a trehalose 6-phosphate synthase (TPS)-like protein from the validamycin biosynthetic pathway, revealed that the enzyme does not catalyze the coupling between uridine diphosphate (UDP)-glucose and glucose 6-phosphate, but catalyzes an unprecedented non-glycosidic C-N coupling of guanosine diphosphate (GDP)-valienol and validamine 7-phosphate to give validoxylamine A 7 0 -phosphate with an a,a-amino linkage ( Figure 2 ) (Asamizu et al., 2011) . This finding raises fundamental questions as to how a GT-like enzyme catalyzes a condensation of two non-sugar molecules with retention of configuration.
The current paradigm suggests that retaining GTs, such as the GT family-20 TPS (OtsA) and family-5 glycogen synthases (based on the CAZy classification), function via an internal return (S N i)-like mechanism involving an oxocarbenium ion-like transition state, as opposed to a double S N 2 displacement mechanism (Lairson et al., 2008; Lee et al., 2011) . Seminal X-ray crystallography and linear free energy relationship studies by Davis and coworkers on OtsA using validoxylamine A 7 0 -phosphate as a transition state mimic demonstrate the involvement of a frontface nucleophilic attack involving hydrogen bonding between the leaving group (UDP) and the nucleophile (acceptor sugar), in the OtsA reaction (Errey et al., 2010; Lee et al., 2011) . The leaving-group phosphate is proposed to act as a base to deprotonate the acceptor. Furthermore, kinetic isotope effects indicate the participation of a highly dissociative oxocarbenium ion-like transition state in the reaction (Lee et al., 2011) . However, as the donor substrate for VldE is an activated pseudosugar (GDP-valienol), oxocarbenium ion formation is not possible in the VldE-catalyzed coupling reaction. Moreover, little is known about the molecular basis governing PsGT substrate specificity and catalytic mechanism, and whether or not the amino group on the acceptor is necessary for the reaction to occur. To investigate the substrate specificity and catalytic mechanism of VldE and its relationship with OtsA, we carried out careful biochemical and kinetic studies of recombinant VldE, OtsA, and their chimeric proteins, which were engineered by swapping the N-and C-terminal domains of the two proteins, with a variety of synthetically prepared sugar (pseudosugar) donor and acceptor substrates. Here, we report new insights into the distinct substrate specificity and catalytic activities of OtsA and VldE and their chimeric proteins.
RESULTS
Comparative Analysis of VldE, Escherichia coli OtsA, and Streptomyces coelicolor OtsA The PsGT VldE is highly similar to the TPS OtsA. X-Ray crystal structures of VldE from Streptomyces hygroscopicus subsp. limoneus and the well-studied UDP-forming Escherichia coli TPS (OtsA(Eco)) demonstrated that both proteins adopt a GT-B fold with the C-terminal domain generally accepted to be the one that recognizes a nucleotidylated sugar donor and the N-terminal domain recognizes a sugar acceptor, with the domains connected by a linker (Cavalier et al., 2012; Gibson et al., 2002) . It has been reported that OtsA utilizes a sequential ordered bi-bi mechanism in which UDP-glucose (the sugar donor) binds to the active site first and is followed by glucose 6-phosphate (the sugar acceptor) (Lee et al., 2011) . The conserved architectural structures of VldE and OtsA with two distinct substrate binding domains provide an unusual opportunity to investigate their catalytic properties through domain swapping. Therefore, we set out to create chimeric proteins of VldE and OtsA and investigate the effects of each domain on Table 1 ). To some extent, the enzyme also processes UDPglucose (K m >1.5 mM) and CDP-glucose (K m >4 mM), albeit with much lower binding affinity. No product can be detected in the reaction with dTDP-glucose ( Figure S1 ). Whereas OtsA(Sco) has broad substrate specificity, recognizing GDP-, ADP-, UDP-, and CDP-glucose as sugar donors, VldE was only known to recognize GDP-valienol as a pseudosugar donor. No other nucleoside diphosphate (NDP)-valienols have previously been tested, because the corresponding nucleotidyltransferase enzyme VldB appeared to prefer GTP as substrate, and produces GDP-valienol . The preference of VldE toward GDP-valienol was also supported by its X-ray crystal structures (Cavalier et al., 2012) . However, it was unclear whether VldE can process other NDP-valienols. Therefore, we prepared all five possible NDP-valienols and evaluated the substrate preference of VldE, whether or not it can process other NDP-valienols. GDP-, ADP-, and CDP-valienols were prepared from valienol 1-phosphate and their corresponding nucleotidyl triphosphates (GTP, ATP, or CTP), using VldB , whereas UDP-and dTDP-valienol were prepared from valienol 1-phosphate and UTP and deoxythymidine triphosphate (dTTP), respectively, using RmlA-L89T, an engineered broad-spectrum nucleotidyltransferase (Moretti et al., 2011) , kindly provided by Prof. Jon Thorson at the University of Kentucky ( Figures S2A and S2B ). Although RmlA-L89T has been known to have relaxed substrate specificity toward various sugar phosphates (Moretti et al., 2011) , the present study showed that RmlA-L89T is also able to process an unsaturated carbasugar phosphate. Incubation of VldE with NDP-valienols and validamine 7-phosphate revealed that VldE only accept GDP-valienol as substrate ( Figure S2C ). Based on the similar GDP-sugar substrates, high sequence similarity, and their Streptomyces origin, we selected OtsA(Sco) for domain-swapping experiments with VldE.
Design and Construction of VldE/OtsA(Sco) Chimeras Guided by the crystal structures of VldE and predicted secondary structure and folding of OtsA(Sco)-as its crystal structures are not yet available-we designed chimeric PsGTs using these two proteins. Secondary structure and protein folding prediction were performed using the Phyre2 program (http://www.sbg.bio. ic.ac.uk) (Figures S3A and S3B) (Kelley and Sternberg, 2009) . The sites for domain swapping were chosen within loops (between amino acid residues Thr275 and Glu276 of OtsA(Sco) and residues Gly266 and Arg267 of VldE), which are located in the linker regions of the two proteins. We chose these positions with the expectation that the secondary structures of the N-and C-terminal domains would not be disrupted and that they provide the least interruption of the tertiary protein structure (Figure 3A) . The model structures of the expected chimeric proteins were then reanalyzed using Phyre2. The results showed that the modeled structures for chimera-1 (N terminus of VldE, C terminus of OtsA(Sco)) and chimera-2 (N terminus of OtsA(Sco), C terminus of VldE) ( Figure 3B ) share 71% and 61% similarity, respectively, with that of VldE, with 100% confidence ( Figure 3B ) (Kelley and Sternberg, 2009 ). The DNA fragments representing the N-and C-terminal domains of the enzymes were then amplified by PCR; the N-terminal fragment from one parental gene was replaced with an equivalent fragment of the second parental gene and vice versa. As no convenient restriction sites are available within the desired region of the genes, cloning of the chimeric genes was performed by blunt end ligations between the two fragments, and the products were ligated to the pRSET B vector ( Figure 3C ). The genes were expressed in E. coli BL21(DE3) pLysS, providing soluble recombinant chimera-1 and chimera-2 ( Figure 3D ).
Chimera-1 Can Produce a Hybrid Pseudoaminodisaccharide Chimera-1, together with VldE and OtsA(Sco), were characterized using either GDP-valienol or GDP-glucose as the sugar donor and validamine 7-phosphate or glucose 6-phosphate as the sugar acceptor. Both GDP-valienol and validamycin 7-phosphate were prepared according to procedures reported previously (Asamizu et al., 2011) . As expected, chimera-1 was able to catalyze the coupling between GDP-glucose and validamine 7-phosphate to give a hybrid pseudoaminodisaccharide with an apparent K m value of 1.1 ± 0.07 mM and k cat /K m 0.15 s This compound was further confirmed by tandem mass spectrometry analysis, which gave fragment ions at 322, 310, 294, and 178 ( Figure S4B ), indicating the presence of validamine moiety in the product. This hybrid pseudoaminodisaccharide product is relatively unstable, readily degrading under the reaction conditions. Prolonged incubation (more than 1 hr) resulted in a significant reduction of the product intensity in the ESI-MS. As a result, numerous attempts to isolate the compound from the reaction mixtures were unsuccessful. Interestingly, chimera-1 can also catalyze the coupling between GDP-valienol and validamine 7-phosphate ( Figure 4C ), albeit with a much lower conversion rate. The enzyme affinity to GDP-valienol (K m >10 mM) is significantly lower than to GDPglucose (K m 1.1 ± 0.07 mM), indicating that GDP-valienol is not a preferred substrate for chimera-1 ( Figure 5 ). This is consistent with the fact that chimera-1 contains the OtsA C-terminal domain. However, when GDP-valienol was used as a donor in the parent protein OtsA(Sco), with either validamine 7-phosphate or glucose 6-phosphate as acceptor, no products could be observed ( Figures 4B and 4N ), suggesting that the C-terminal domain of OtsA can only accept GDP-valienol (a pseudosugar) as substrate when it is fused with the N-terminal domain of VldE.
Chimera-2 Displays OtsA Activity As chimera-2 consists of the N-terminal domain of OtsA(Sco) and the C-terminal domain of VldE, the protein was incubated with GDP-valienol and glucose 6-phosphate. It is expected that this reaction would furnish a hybrid product similar to that of chimera-1, except in a reverse combination. However, we discovered that chimera-2 is unable to process the two substrates to produce the desired product ( Figure 4P ). Nor can it catalyze the coupling between GDP-valienol and validamine 7-phosphate ( Figure 4D ). However, interestingly, the protein is able to catalyze the condensation of GDP-glucose and glucose 6-phosphate to give trehalose 6-phosphate (Figures 4H and S4C), suggesting that the C-terminal domain of chimera-2, which originates from VldE, is able to recognize GDP-glucose (K m 3.56 ± 0.38 mM) as substrate.
VldE Prefers GDP-Valienol over GDP-Glucose as Substrate
The ability of chimera-2 to process GDP-glucose and glucose 6-phosphate has urged us to reinvestigate the substrate specificity of VldE and whether VldE itself can process these substrates. The enzyme was incubated with GDP-glucose and glucose 6-phosphate, as well as with GDP-glucose and validamine 7-phosphate. The reaction was terminated after 1 hr and the products were immediately analyzed by ESI-MS. While incubation of VldE with GDP-glucose and glucose 6-phosphate did not give any product ( Figure 4E ), it can in fact process GDPglucose and validamine 7-phosphate to give a product (m/z 418 Figures 4I and S4A) , which is identical to that of chimera-1. As described above, this hybrid compound is relatively unstable, requiring early termination of incubation and immediate analysis of the sample for clear observation of the product. Its low stability may explain why this product was not observed in our previous experiments (Asamizu et al., 2011) . In light of the present results, we conclude that the C-terminal domain of VldE can recognize both GDP-valienol (K m 0.06 ± 0.012 mM) (Asamizu et al., 2011) and GDP-glucose (K m >2.2 mM) as substrate, but with >37-fold greater affinity toward GDP-valienol.
The Role of the N-Terminal Domain in Governing the Type of Bonding
One of the differences between OtsA and VldE is that OtsA catalyzes the formation of a glycosidic bond (C-O bond), whereas VldE forms a nitrogen linkage (C-N bond). Based on the results of our biochemical studies of chimera-1 and chimera-2, we concluded that the N-terminal domains of VldE and OtsA(Sco) have more rigid substrate specificity or are mechanistically more restricted than their C-terminal domains. Chimera-1, which contains the N-terminal domain of VldE, only recognizes validamine 7-phosphate, but not glucose 6-phosphate, whereas chimera-2, which contains the N-terminal domain of OtsA, only recognizes glucose 6-phosphate, but not validamine 7-phosphate, as an acceptor molecule. To confirm whether this rigid substrate specificity is also observed in the parent proteins, we incubated VldE with GDP-valienol and glucose 6-phosphate ( Figures 4M and S4C) , and OtsA(Sco) with GDP-glucose and validamine 7-phosphate ( Figures 4J and S4D ). As expected, both reactions did not give any desired products ( Figure S4C and S4D), confirming that the N-terminal domains of VldE and OtsA(Sco) play a significant role in governing the type of substrates and/or catalytic reactions. However, whether this is due to the differences in nucleophilicity (-OH versus -NH 2 ) or the presence of a ring oxygen (sugar versus cyclitol) of the acceptor molecules was unclear.
Amino Group Is Necessary for Pseudoglycoside Formation To investigate whether nucleophilicity or the presence of a ring oxygen of the acceptor molecule plays a bigger role in the coupling reaction, we synthesized validol 7-phosphate, a validamine 7-phosphate analog in which the C-1 amino group has been replaced with a hydroxy group, and used it as the acceptor molecule. The compound was synthesized from tetrabenzylvalidone (Asamizu et al., 2011 ) following a procedure shown in Figure S4E . 
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See also Figure S5 . Validol 7-phosphate was then incubated with chimera-1 and chimera-2 in the presence of either GDP-valienol or GDPglucose. The results showed that chimera-1 did not recognize validol 7-phosphate as acceptor molecule, indicating that the amino group is critical for the PsGT reaction ( Figures 4S and  S4F ). On the other hand, chimera-2 can only catalyze the coupling between GDP-glucose and validol 7-phosphate (Figure 4T ), but not between GDP-valienol and validol 7-phosphate ( Figure S4F ), which is in agreement with the notion that the amino group is required for the pseudoglycosidic coupling to occur. This was further confirmed by testing validol 7-phosphate with the parent proteins VldE and OtsA. As expected, VldE was not able to catalyze the coupling between GDP-valienol and validol 7-phosphate ( Figure 4Q ), whereas OtsA was able to couple GDP-glucose and validol 7-phosphate to give a hybrid product ( Figure 4R ), a,a-pseudotrehalose 7 0 -phosphate, which upon VldH hydrolysis gave a,a-pseudotrehalose ( Figure S4G ) (Bock et al., 1991) . Although OtsA can recognize validol 7-phosphate as substrate, kinetic studies of OtsA with GDP-glucose and validol 7-phosphate revealed the enzyme affinity to validol 7-phosphate (K m >10 mM) is significantly lower than to glucose 6-phosphate (K m 0.587 ± 0.11 mM) ( Figure 5 ; Table 1 ).
Based on these results, we proposed that strong nucleophilic character is key for pseudoglycoside formation involving GDPvalienol, and that in the OtsA reaction the ring oxygen in the sugar acceptor (glucose 6-phosphate) plays a significant role for the glycosylation reaction to take place efficiently.
VldE Recognizes 1-Amino-1-Deoxyglucose 6-Phosphate as an Acceptor Molecule To further confirm the importance of amino group in pseudoglycoside formation, we tested 1-amino-1-deoxyglucose 6-phosphate, which resembles glucose 6-phosphate but with an amino group at the anomeric (C-1) position, as sugar acceptor. This compound was prepared by stirring glucose 6-phosphate in 600 mM ammonium acetate at room temperature for 2 days (Lim et al., 2006; Vetter and Gallop, 1995) . Incubation of VldE with GDP-valienol and 1-amino-1-deoxyglucose 6-phosphate, however, did not give the expected product pseudoaminotrehalose ( Figure S6A) . Interestingly, careful analysis of the reaction mixture by ESI-MS and high-performance liquid chromatography (HPLC) revealed the presence of valienamine, a hydrolytic product of validoxylamine A and the synthetic precursor of the antidiabetic drug voglibose. No valienamine was observed in the reaction with boiled enzyme, indicating that the compound is produced from an enzymatic reaction ( Figures S6A and  S6B) . Therefore, we postulated that the coupling reaction between GDP-valienol and 1-amino-1-deoxyglucose 6-phosphate Table S1 .
did occur and that the product, pseudoaminotrehalose, is then hydrolyzed to valienamine via an imine intermediate ( Figure 6 ).
The N-Terminal Domain Plays a Significant Role in the NDP-Sugar Preference of VldE and OtsA X-Ray crystal structures of OtsA(Eco) and VldE bound to UDP and GDP, respectively, demonstrated the sites and specific NDP binding pockets in the C-terminal domains of the enzymes, which is consistent with the notion that the C-terminal domains determine the selection of the NDP-sugar or NDP-cyclitol substrates. However, incubations of chimera-1 or chimera-2 with GDP-, ADP-, UDP-, CDP-, and dTDP-glucose individually with their corresponding acceptor molecules revealed that chimera-1, which contains the C-terminal domain of OtsA(Sco), can only process GDP-glucose (similar to VldE) ( Figure S4H ), whereas chimera-2, which contains the C-terminal domain of VldE, can accept all NDP-glucoses except dTDP-glucose as substrates, similar to OtsA(Sco) ( Figure S4H ). These are completely opposite to the NDP specificity of the parent proteins from which the C-terminal domains originate. Therefore, in contrast to the current paradigm for GT-B GTs, the results strongly suggest that the N-terminal domains of OtsA and VldE play a significant role in selecting the type of nucleotidyl diphosphate moiety of the donor sugars.
DISCUSSION
Based on their X-ray crystal structures, OtsA and VldE are grouped into the GT-B structural type. The conserved architectural structures of this group of proteins with two distinct substrate binding domains have made them an attractive target for domain-swapping-based engineering. Domain swapping is a common strategy for engineering proteins that have distinct catalytic or substrate binding regions. Therefore, conceptually it is a promising and attainable approach for mechanistic studies or diversification of GT-B type GTs. However, in practice this approach is not always straightforward, as identifying ideal recombination sites within two different GTs and preserving their catalytic functions are sometimes challenging. Nevertheless, numerous successful constructions of functional chimeric GTs have been reported over the past 15 years, most notably those from the urdamycin pathway UrdGT1b and UrdGT1c (Hoffmeister et al., 2001) , the plant flavonoid GTs UGT74F1 and UGTT74F2 (Cartwright et al., 2008) , and the glycopeptide GTs GtfB and Orf10* (Truman et al., 2009 ). However, all of these GT pairs are highly homologous and perform analogous glycosylations; UrdGT1b and UrdGT1c share 91% sequence identity, UGT74F1 and UGTT74F2 possess 76% identity, and GtfB and Orf10* share 70% identity. On the other hand, VldE and OtsA(Sco) only share 29% amino acid sequence identity. Therefore, our success in constructing functional chimeras from these two proteins is a rather fortunate event. More importantly, it provides evidence that both VldE and OtsA(Sco) are amenable to protein engineering through domain-swapping technology. As predicted in most, if not all, GT-B GTs, the C-terminal domains of OtsA and VldE are believed to interact with the sugar or pseudosugar donors and the N-terminal domain interacts with the acceptors. X-Ray crystal structures of VldE in complex with GDP and validoxylamine A 7 0 -phosphate showed interactions between purine (from GDP) and Arg321, Asn323, Asn361, and Thr366 residues in the C-terminal domain, whereas in those of E. coli OtsA showed interactions of the smaller pyrimidine (from UDP) with Leu344, Ile295, Pro297, and His338 residues. S. coelicolor OtsA, however, differs from E. coli OtsA in that it prefers purine-derived NDP substrates. However, in contrast to VldE, which strictly uses GDP-valienol, OtsA(Sco) can use both GDP-and ADP-glucose (purine analogs) and, to a smaller extent, UDP-and CDP-glucose (pyrimidine analogs). Interestingly, despite ample evidence to support the distinctive roles of the N-and C-terminal domains, we found, through characterization of the chimeric proteins, that the N-terminal domains of VldE and OtsA(Sco) also play a significant role in the NDP-sugar preference. Chimera-1, which harbors the C-terminal domain of OtsA(Sco) (which recognizes GDP-, ADP-, UDP-, and CDP-glucoses), can only process GDP-glucose, whereas chimera-2, which contains the C-terminal domain of VldE (which recognizes only GDP-valienol), can accept GDP-, ADP-, UDP-, and CDP-glucoses as substrates. Therefore, we propose that, in addition to or in lieu of the C-terminal domain, the N-terminal domains of OtsA and VldE play a significant role in selecting the type of NDP moiety of the donor sugars. As most of the catalytic events in GT-B GTs occur in the interface of the two domains, it is possible that the N-terminal domain is actually involved in the primary recognition of the NDP-sugar(s), presumably when the enzyme is in its ''open'' form, and the donor substrate is subsequently directed to its binding pocket in the C-terminal domain side of the interface.
The N-terminal domains of OtsA(Sco) and VldE are also responsible for the selection of the acceptor molecules. Accordingly, chimera-1, which consists of the N-terminal domain of VldE and the C-terminal domain of OtsA(Sco), is able to utilize GDP-glucose and validamine 7-phosphate as substrates. However, chimera-2, which consists of the N-terminal domain of OtsA(Sco) and the C-terminal domain of VldE, is unable to couple GDP-valienol and glucose 6-phosphate. In fact, this was not due to the lack of activity of the enzyme, as it can catalyze the coupling between GDP-glucose and glucose 6-phosphate to give trehalose 6-phosphate. Therefore, we propose that a strong nucleophilic group in the acceptor is necessary for a successful coupling reaction involving a pseudosugar donor. This was corroborated by incubating VldE with GDP-valienol and 1-amino-1-deoxyglucose 6-phosphate. Although the expected product pseudoaminotrehalose could not be directly observed, the identification of valienamine in the reaction mixtures with an active enzyme, but not in those with a heat-inactivated enzyme, strongly suggests that pseudoaminotrehalose was actually formed, but was spontaneously hydrolyzed to valienamine ( Figure 6 ). On the other hand, incubation of VldE with GDP-valienol and validol 7-phosphate did not give any products, further confirming the importance of the amino group in the reaction. The notion that the nucleophilicity of the acceptor molecule plays a significant role in the catalytic activity of PsGT enzymes is consistent with the fact that all natural products whose formations are postulated to involve PsGTs contain amino linkages (Mahmud, 2003) .
Some important insights into the distinct substrate specificity and reactivity of Ots(Sco), VldE, and their chimeras were also gained from the kinetics studies ( Figure 5 ; evident from the apparent specificity constants (k cat /K m values) of OtsA(Sco) with various substrates that this enzyme is highly optimized for its natural substrates, NDP-glucose and glucose 6-phosphate. OtsA(Sco) does not recognize GDP-valienol or validamine 7-phosphate as substrates (Figure 4) . Although the enzyme uses validol 7-phosphate as an acceptor molecule, the relative catalytic rate for this compound is significantly low, despite their shared chair conformation, suggesting that the ring oxygen in the sugar acceptor (glucose 6-phosphate) plays a significant role for its higher binding affinity and/or the glycosylation reaction to take place efficiently.
Second, kinetics data also suggest that the PsGT VldE can only optimally process GDP-valienol and validamine 7-phosphate. Although it can also use GDP-glucose as a donor molecule (only when it is incubated with validamine 7-phosphate as an acceptor), in comparison with GDP-valienol its affinity to the enzyme and catalytic rate are significantly low. This unambiguously confirmed the distinct substrate specificity of OtsA(Sco) and VldE, and that VldE is a dedicated PsGT, not a GT with broad substrate specificity.
Third, compared with other substrates, GDP-valienol shows unusually high binding affinity to VldE; in fact, it is considerably higher than that of GDP-glucose to OtsA ( Figure 5 ). This is likely due to the half-chair conformation of the cyclohexene ring of GDP-valienol, which resembles the oxocarbenium ion transition state. Indeed, a number of natural and synthetic compounds containing this structure have been used as potent competitive inhibitors of biologically important sugar hydrolases. These include the a-glucosidase inhibitor acarbose (used as an antidiabetic drug), the trehalase inhibitor validamycin A (used as an antifungal), and the neuraminidase inhibitor oseltamivir (Tamiflu, used as an anti-influenza drug). Interestingly, while the VldE product validoxylamine A 7 0 -phosphate also contains an oxocarbenium ion-like structure, which arguably can inhibit the enzyme activity, the apparent k cat /K m values of VldE remain relatively high (2.0 s À1 mM À1 for GDP-valienol and 0.39 s À1 mM À1 for validamine 7-phosphate). Thus, we speculate that the binding affinity of the product to the enzyme is lower than that of the Table 1 . See also Figure S5 .
substrate GDP-valienol as, in addition to the oxocarbenium ion-like structure, GDP-valienol has strong enzyme-GDP hydrogen-bonding interactions, which is more likely to have competitive advantages over validoxylamine A 7 0 -phosphate. Indeed, the apparent k cat /K m values of VldE for its natural substrates are about half of those of OtsA ( Figure 5 ; Table 1 ), although this may be merely due to intrinsic factors related to the reactivity of the pseudosugar donor.
Fourth, although both chimera-1 and chimera-2 are functionally active, their apparent k cat /K m values are relatively low. It is unclear, however, whether this is due to the inherent nature of engineered proteins of two different origins or to suboptimal swapping sites in the linker regions. Nevertheless, we observed a meaningful shift in the specificity constants of chimera-2 to glucose 6-phosphate and validol 7-phosphate from those of the parent protein OtsA(Sco). Compared with the distinct k cat / K m values for glucose 6-phosphate and validol 7-phosphate in OtsA(Sco), both substrates appear to have comparable k cat /K m values in chimera-2. Whether this is due to the influence of the C-terminal domain of VldE (in chimera-2) remains to be investigated.
SIGNIFICANCE
To date there are more than 150,000 genes encoding proteins across more than 90 known families of GTs listed in the databases, and this number is growing rapidly. However, only a fraction of them have been functionally characterized. The challenge lies in the fact that not all of them are ''true'' GT enzymes. Our recent study revealed that some putative GTs can catalyze a non-glycosidic C-N coupling in the biosynthesis of pseudosugar-containing natural product. The pseudosugar-transferase enzymes, or PsGTs, might have evolved from ancestral GTs to the extent that they can recognize non-sugars as donor substrates. However, little is known about their substrate selectivity and catalytic mechanisms. This lack of knowledge hinders the exploitation of their full potential and may pose critical barriers to progress in glycoscience, drug discovery, and related fields. Here, we describe our success in engineering two chimeric proteins from the GT OtsA(Sco) and the PsGT VldE and their characterizations through comparative biochemical and kinetics studies. The studies not only provide new insights into the substrate selectivity and catalytic function of these proteins, but also open up new opportunities in the broad area of glycoscience and drug discovery, such as facilitating the development of new technical capabilities to generate carbohydrate mimetics, redesign glycoconjugates, and create novel bioactive natural products.
EXPERIMENTAL PROCEDURES
Domain Swapping between VldE and OtsA(Sco) DNA fragments of the VldE-N-terminal domain, VldE-C-terminal domain, OtsA-N-terminal domain, and OtsA-C-terminal domain were amplified by PCR using PfuTurbo DNA polymerase (Agilent Technology) and the listed primer pairs (Table S1 ). The 5 0 -end of the VldE-N-terminal domain DNA fragment was digested with XhoI and the 3 0 -end of the OtsA-C-terminal domain DNA fragment was digested with EcoRI. The resulting DNA fragments were ligated into the vector pRSET B (Invitrogen), predigested with XhoI and EcoRI, to give pRSET-B-chimera-1. Similarly, the 5 0 -end of OtsA-N-terminal domain DNA fragment and the 3 0 -end of VldE-C-terminal domain DNA fragment were digested with BamHI and EcoRI, respectively, and ligated into pRSET B, predigested with BamHI and EcoRI, to give pRSET-B-chimera-2. The identity of the chimera-1 and chimera-2 genes was confirmed by Sanger DNA sequencing in the Center for Genome Research and Biocomputing at Oregon State University.
Chimera-1, Chimera-2, OtsA(Sco), OtsA(Eco), VldB, VldE, and VldH Production and Purification pRSET-B-chimera-1, pRSET-B-chimera-2, pRSET-B-otsA(Sco), pRSET-BotsA(Eco), pET20-vldB, pRSETB-vldE, and pRSETB-vldH were used to transform E. coli BL21(DE3) pLysS. Transformants were grown overnight at 37 C on LB agar plates containing ampicillin (100 mg/ml) and chloramphenicol (25 mg/ml). A single colony was inoculated into LB medium (3 ml) containing ampicillin (100 mg/ml) and chloramphenicol (25 mg/ml), and cultured at 37 C for 6 hr, and this seed culture (1 ml) was transferred into a 500-ml flask containing LB medium (100 ml), containing ampicillin (100 mg/ml) and chloramphenicol (25 mg/ml), and grown at 28 C until OD 600 reached 0.6. The temperature was then reduced to 18 C, and after 2 hr of adaptation, isopropyl-b-D-thiogalactopyranoside was added to a final concentration of 0.1 mM to induce the C-terminal hexahistidine-tagged VldB and the N-terminal hexahistidinetagged chimera-1, chimera-2, OtsA(Sco), OtsA(Eco), VldE, and VldH proteins. After further growth for 14 hr, the cells were harvested by centrifugation (5,000 rpm, 10 min, 4 C) and stored at À80 C until use.
Cell pellets from 50 ml of culture were washed with binding (B) buffer (40 mM NaH 2 PO 4 [pH 8.0], 300 mM NaCl, 10 mM imidazole) (1 ml) and centrifuged (4,000 rpm, 10 min, 4 C). Then, B buffer (1 ml) was added and the mixtures were sonicated (8 W, 15 s, four times). After centrifugation (14,500 rpm, 20 min, 4 C), the supernatant was purified using an Ni-NTA spin column (Qiagen) at 4 C using washing (W) buffer (40 mM NaH 2 PO 4 [pH 8.0], 300 mM NaCl, 20 mM imidazole) (2 3 600 ml) and elution (E) buffer (40 mM NaH 2 PO 4 [pH 8.0] containing 300 mM NaCl and 500 mM imidazole) (500 ml). Eluted proteins were dialyzed against dialysis buffer (10 mM Tris-HCl [pH 7.5], 0.1 mM DTT, 1 mM MgCl 2 ) (1 l) three times for 3 hr each. Purified proteins were analyzed by SDS-PAGE and concentrated by ultrafiltration using Amicon YM-10 (Millipore). Protein concentration was determined using the Bradford assay (Bio-Rad) using BSA as a standard.
Preparation of NDP-Valienol NDP-valienol was prepared according to a reported procedure . Briefly, valienol 1-phosphate (6 mM) was incubated with ATP, GTP, CTP, UTP, or dTTP (6 mM) in the presence of VldB or RmlA-L89T (10 mM) and MgCl 2 (10 mM) in Tris-HCl buffer (50 mM, pH 7.5) at 30 C, and the progress of the reactions was monitored by ESI-MS. After 4 hr, the reactions were quenched with an equal volume of MeOH and centrifuged (14,500 rpm, 5 min, 4 C).
Chemical syntheses of validol 7-phosphate and 1-amino-1-deoxyglucose 6-phosphate are described in Supplemental Experimental Procedures.
Glycosyltransferase Assays
The catalytic activity of VldE, OtsA(Sco), OtsA(Eco), chimera-1, and chimera-2 was examined using NDP-glucoses or NDP-valienols as sugar donor and glucose 6-phosphate, validamine 7-phosphate, or validol 7-phosphate as sugar acceptor. Each reaction (100 ml) contained donor substrate (5 mM), acceptor substrate (5 mM), protein (10 mM), MgCl 2 (10 mM), and Tris-HCl (50 mM, pH 7.5). The reaction mixtures were incubated at 30 C and aliquots (10 ml) of the reactions were collected at 1, 2, 3, 5, and 12 hr, quenched with an equal volume of MeOH, and centrifuged (14,500 rpm, 5 min, 4 C).
The supernatants were analyzed by ESI-MS.
HPLC Analysis of VldB, RmlA-L89T, VldE, and Chimera-1 Products The reactions were quenched by adding two volumes of MeOH and centrifuged. The supernatants were analyzed by HPLC (Shimazu SPD-20A system) with a C18 column (YMC-Pack ODS-A, 250 3 4.6 mm, 5 mm) using 0.5% MeOH in H 2 O containing 10 mM NH 4 HCO 3 as eluent at a flow rate of 1 ml/min. Elution profiles were monitored at 210 nm.
Kinetic Analysis of VldE, OtsA, Chimera-1, and Chimera-2 K m and k cat values for VldE, OtsA, chimera-1, and chimera-2 were determined by using the phosphopyruvate kinase (PK) and lactate dehydrogenase (LDH) coupled assay (Sigma-Aldrich). The reaction mixture (100 ml) contained TrisHCl buffer (50 mM, pH 7.5), MgCl 2 (5 mM), VldE (1 mM), phosphoenolpyruvate (1.5 mM), reduced nicotinamide adenine dinucleotide (NADH) (0.5 mM), PK (37 U), and LDH (46 U), in addition to a serial dilution of the donor substrate and 2 mM of the acceptor substrate for the determination of the value for the donor substrate, and a serial dilution of the acceptor substrate and 2 mM donor substrate for the determination of the value for acceptor substrate. Oxidation of NADH to NAD + was monitored in 96-well plates using a spectrophotometric microplate reader at 340 nm. Reaction mixtures lacking the enzyme were used as negative control (blank). The data were collected in triplicate. A Michaelis-Menten plot (SigmaPlot, Systat Software) was used for determination of K m and k cat values. 
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